The $ 300,000 drug that could extend the life of infants with cystic fibrosis


A life-saving $ 300,000-a-year medicine for cystic fibrosis for the first time subsidized for infants in a breakthrough that could extend their lives.

The medicine Kalydeco will be subsidized by August for children one slashing the cost to just $ 40.30 per script or $ 6.50 if families have a concession card.

Cystic fibrosis clogs the body's organs with thick sticky mucus and leaves sufferers with a life expectancy of just 38 years.



Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.